Understanding Diabetic Kidney Disease: What are the best options for clinical management?
Dr. Per-Henrik Groop outlines that diabetic kidney disease is common and associated with a grim prognosis. Optimal glucose control is central to limiting the risk of renal complications. Newer antidiabetic drugs can play a welcome role to optimally treat these patients.
This lecture was recorded during the Asian Interchange on Diabetes meeting, held in Bangkok on July 30-31, 2016
Video navigation menu
- Kidney disease in diabetes greatly enhances risk of CV morbidity and mortality 1:52
- Importance of blood glucose control - a five finger rule to optimally treat diabetic kidney disease 8:22
- Achieving glucose control without causing harm - DPP4 inhibitors and GLP-1 agonists and renal function 12:21
- Pre-specified renal endpoints with SGLT2 inhibition in the EMPA-REG OUTCOME trial 20:03
- Implications of the renal results of empagliflozin 22:34
- Why does empagliflozin work so well and how can we benefit from it in clinical practice? 24:00